Conference Recap

Conference Recap

Follicular Lymphoma Highlights From ASH 2022

Follicular lymphoma highlights from ASH 2022 include a comparison of rituximab to watch-and-wait and updates on tazemetostat and mosunetuzumab, as...

Pages